Laurence Klotz1. 1. Professor of Surgery, University of Toronto, Sunnybrook Health Sciences Centre, 2075 Bayview Ave. #MG408, Toronto, Ontario M4N 3M5, Canada.
Abstract
OBJECTIVES: Prostate capsule sparing radical cystectomy (PSRC) is a modification of the traditional surgical approach to radical cystectomy and neobladder, which offers the prospect of improved preservation of erectile function and continence. METHODS: This is a review of the literature regarding the oncologic and quality of life outcomes of this approach for transitional cell carcinoma of the bladder, and a comparison of these results to conventional cystoprostatectomy and neobladder. RESULTS: There are a limited number of studies addressing prostate capsule or prostate sparing cystectomy. All are retrospective, non-comparative and not uniform in terms of patient selection and technique. Long-term follow-up is lacking. The incidence of synchronous and or metachronous prostate cancer and TCC of the prostatic urethra is lower than that found in conventional cystoprostatectomy. This is likely due to pre-operative patient selection, restricting the procedure to those with no evidence of prostatic involvement by either disease. The local recurrence rate is 5%, comparable to standard cystoprostatectomy. Recurrence free and overall survival rates are comparable.
OBJECTIVES: Prostate capsule sparing radical cystectomy (PSRC) is a modification of the traditional surgical approach to radical cystectomy and neobladder, which offers the prospect of improved preservation of erectile function and continence. METHODS: This is a review of the literature regarding the oncologic and quality of life outcomes of this approach for transitional cell carcinoma of the bladder, and a comparison of these results to conventional cystoprostatectomy and neobladder. RESULTS: There are a limited number of studies addressing prostate capsule or prostate sparing cystectomy. All are retrospective, non-comparative and not uniform in terms of patient selection and technique. Long-term follow-up is lacking. The incidence of synchronous and or metachronous prostate cancer and TCC of the prostatic urethra is lower than that found in conventional cystoprostatectomy. This is likely due to pre-operative patient selection, restricting the procedure to those with no evidence of prostatic involvement by either disease. The local recurrence rate is 5%, comparable to standard cystoprostatectomy. Recurrence free and overall survival rates are comparable.
Authors: L Henningsohn; H Wijkström; J Pedersen; C Ahlstrand; G Aus; K Bergmark; E Onelöv; G Steineck Journal: BJU Int Date: 2003-03 Impact factor: 5.588
Authors: Monica P Revelo; Michael S Cookson; Sam S Chang; M Frances Shook; Joseph A Smith; Scott B Shappell Journal: J Urol Date: 2004-02 Impact factor: 7.450
Authors: Joseph A Pettus; Hikmat Al-Ahmadie; Daniel A Barocas; Theresa M Koppie; Harry Herr; S Machele Donat; Guido Dalbagni; Victor E Reuter; Semra Olgac; Bernard H Bochner Journal: Eur Urol Date: 2007-07-26 Impact factor: 20.096
Authors: Henry Botto; Philippe Sebe; Vincent Molinie; Jean-Marie Herve; Laurent Yonneau; Thierry Lebret Journal: BJU Int Date: 2004-11 Impact factor: 5.588
Authors: R Colombo; F Pellucchi; M Moschini; A Gallina; R Bertini; A Salonia; P Rigatti; F Montorsi Journal: World J Urol Date: 2015-01-11 Impact factor: 4.226